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Mycobacterium tuberculosis has infected approximately one out of every four people 
globally as reported by the CDC. One possible source for an antibiotic solution is the 
Electron Transport Chain. Using M. smegmatis as a model organism, I investigate 
the mycobacterial electron transport chain using known chemical inhibitors and 
identifying whether they have a specific target within the electron transport chain. Two 
oxidoreductases of interest include qcrB and cydA. My current research involves work 
with the CWHM1023 (CB81-family) chemical inhibitor. It is hypothesized that this 
compound acts through targeted inhibition of the qcrB oxidoreductase. This hypothesis 
is based on prior experiments showing a decrease in ATP levels of M. smegmatis following 
exposure to CWHM1023, as well as the discovery of a mutation in qcrB, QcrBA178T, 
conferring resistance to CWHM1023. In an effort to confirm this hypothesis, various 
deletion mutants of qcrB and cydA in M. smegmatis have been constructed using novel 
phage recombineering methods. These mutants are then complemented with either empty 
vector, the original deletion, or a mutant version of the deleted sequence (QcrBA178T) 
in an effort to confirm with certainty the targets of CWHM1023. To test the effects of 
CWHM1023 on the various strains, I utilize the Microplate Alamar Blue Assay (MABA), 
which tests for respiration levels of bacteria through quantification of the reduction of 
blue-colored Resazurin to the pink Resorufin. Numerous MABA experiments have thus 
far been conducted, and have provided promising data supporting qcrB as the target of 
CWHM1023. However, current research directions involve cloning of new complement 
strains that account for possible genetic polar effects given the existence of qcrB and 
CydA in operons. Confirmation of qcrB as the target of CWHM1023 will provide novel 
understanding of the organization of the mycobacterial electron transport chain, and 
ways by which it may be inhibited.
